US 11,980,617 B2
Methods of treating acute depression and/or acute anxiety
Gretchen Snyder, New York, NY (US); Robert Davis, San Diego, CA (US); and Lawrence P. Wennogle, Hillsborough, NJ (US)
Assigned to INTRA-CELLULAR THERAPIES, INC., New York, NY (US)
Appl. No. 16/981,639
Filed by INTRA-CELLULAR THERAPIES, INC., New York, NY (US)
PCT Filed Mar. 15, 2019, PCT No. PCT/US2019/022480
§ 371(c)(1), (2) Date Sep. 16, 2020,
PCT Pub. No. WO2019/178484, PCT Pub. Date Sep. 19, 2019.
Claims priority of provisional application 62/780,004, filed on Dec. 14, 2018.
Claims priority of provisional application 62/682,582, filed on Jun. 8, 2018.
Claims priority of provisional application 62/644,355, filed on Mar. 16, 2018.
Prior Publication US 2021/0060009 A1, Mar. 4, 2021
Int. Cl. A61K 31/4985 (2006.01); A61K 9/00 (2006.01); A61K 31/13 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61K 31/138 (2006.01); A61K 31/155 (2006.01); A61K 31/165 (2006.01); A61K 31/197 (2006.01); A61K 31/343 (2006.01); A61K 31/36 (2006.01); A61K 31/38 (2006.01); A61K 31/381 (2006.01); A61K 31/42 (2006.01); A61K 31/485 (2006.01); A61K 31/55 (2006.01); A61K 31/5513 (2006.01); A61K 38/07 (2006.01); A61P 25/24 (2006.01)
CPC A61K 31/4985 (2013.01) [A61K 9/006 (2013.01); A61K 31/13 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 31/155 (2013.01); A61K 31/165 (2013.01); A61K 31/197 (2013.01); A61K 31/343 (2013.01); A61K 31/36 (2013.01); A61K 31/38 (2013.01); A61K 31/381 (2013.01); A61K 31/42 (2013.01); A61K 31/485 (2013.01); A61K 31/55 (2013.01); A61K 31/5513 (2013.01); A61K 38/07 (2013.01); A61P 25/24 (2018.01)] 35 Claims
 
1. A method of treating acute depression and/or acute anxiety, comprising administering to a patient in need thereof, a therapeutically effective amount of a Compound of Formula I:

OG Complex Work Unit Chemistry
in free, or pharmaceutically acceptable salt form.